No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr3:69432600-69436200 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
2 |
chr3:69433400-69436200 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
3 |
chr3:69433800-69436200 |
Flanking Active TSS |
HMEC |
breast
|
4 |
chr3:69434800-69436200 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
5 |
chr3:69434800-69436200 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
6 |
chr3:69435000-69436200 |
Flanking Active TSS |
NHEK |
skin
|
7 |
chr3:69435200-69436200 |
Enhancers |
Fetal Brain Male |
brain
|
8 |
chr3:69435600-69436200 |
Bivalent Enhancer |
Primary monocytes fromperipheralblood |
blood
|
9 |
chr3:69435600-69436200 |
Flanking Active TSS |
Dnd41 |
blood
|
10 |
chr3:69435600-69438800 |
Weak transcription |
Lung |
lung
|
11 |
chr3:69435800-69436200 |
Bivalent Enhancer |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
12 |
chr3:69435800-69436200 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
13 |
chr3:69435800-69436200 |
Enhancers |
Fetal Heart |
heart
|
14 |
chr3:69435800-69436200 |
Bivalent Enhancer |
Fetal Kidney |
kidney
|
15 |
chr3:69435800-69436400 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
16 |
chr3:69435800-69436400 |
Enhancers |
Fetal Thymus |
thymus
|
17 |
chr3:69435800-69436600 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
18 |
chr3:69435800-69438400 |
Weak transcription |
HUVEC |
blood vessel
|
19 |
chr3:69436000-69436200 |
Bivalent Enhancer |
iPS-15b Cell Line |
embryonic stem cell
|
20 |
chr3:69436000-69436200 |
Enhancers |
Primary T cells from cord blood |
blood
|
21 |
chr3:69436000-69436200 |
Bivalent Enhancer |
Muscle Satellite Cultured Cells |
--
|
22 |
chr3:69436000-69436200 |
Enhancers |
Brain Germinal Matrix |
brain
|
23 |
chr3:69436000-69436200 |
Enhancers |
Skeletal Muscle Female |
skeletal muscle
|
24 |
chr3:69436000-69436200 |
Enhancers |
Thymus |
Thymus
|
25 |
chr3:69436000-69436200 |
Bivalent Enhancer |
NHLF |
lung
|
26 |
chr3:69436000-69436400 |
Enhancers |
Brain Cingulate Gyrus |
brain
|
27 |
chr3:69436000-69436600 |
Weak transcription |
ES-I3 Cell Line |
embryonic stem cell
|
28 |
chr3:69436000-69436600 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
29 |
chr3:69436000-69437200 |
Weak transcription |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
30 |
chr3:69436000-69437200 |
Weak transcription |
Brain Angular Gyrus |
brain
|
31 |
chr3:69436000-69437200 |
Weak transcription |
HSMM |
muscle
|
32 |
chr3:69436000-69437400 |
Weak transcription |
Right Ventricle |
heart
|
33 |
chr3:69436000-69438000 |
Enhancers |
Brain Substantia Nigra |
brain
|
34 |
chr3:69436000-69438400 |
Weak transcription |
Primary hematopoietic stem cells |
blood
|
35 |
chr3:69436000-69438400 |
Weak transcription |
Primary hematopoietic stem cells short term culture |
blood
|
36 |
chr3:69436000-69438400 |
Weak transcription |
Rectal Mucosa Donor 31 |
rectum
|
37 |
chr3:69436000-69438600 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
38 |
chr3:69436000-69438600 |
Weak transcription |
Brain Anterior Caudate |
brain
|
39 |
chr3:69436000-69438600 |
Weak transcription |
Fetal Lung |
lung
|
40 |
chr3:69436000-69438800 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
41 |
chr3:69436000-69438800 |
Weak transcription |
Brain Dorsolateral Prefrontal Cortex |
brain
|
42 |
chr3:69436000-69439200 |
Weak transcription |
Esophagus |
oesophagus
|
43 |
chr3:69436000-69439400 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
44 |
chr3:69436000-69439600 |
Enhancers |
Brain Hippocampus Middle |
brain
|
45 |
chr3:69436000-69441400 |
Weak transcription |
Left Ventricle |
heart
|
46 |
chr3:69436000-69441400 |
Weak transcription |
Spleen |
Spleen
|